Streptococcus pneumoniaemeningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine
Author(s) -
Jennie Johnstone,
Gregory J. Tyrrell,
Thomas J. Marrie,
Sipi Garg,
James D. Kellner,
the Streptococcus pneumoniae Alberta Team group
Publication year - 2011
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2011/179170
Subject(s) - streptococcus pneumoniae , medicine , meningitis , pneumococcal conjugate vaccine , pediatrics , pneumococcal infections , vaccination , epidemiology , conjugate vaccine , incidence (geometry) , cohort , mortality rate , immunology , immunization , antibiotics , microbiology and biotechnology , biology , antibody , physics , optics
To describe the epidemiology, clinical characteristics, microbiology and outcomes of patients of all ages with Streptococcus pneumoniae meningitis two years pre- and postintroduction of a S pneumoniae 7-valent conjugate vaccine program in Alberta in children <2 years of age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom